MLICM
PAVM icon

Metropolitan Life Insurance Company (MetLife)’s PAVmed PAVM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31
Closed -$119K – 2816
2021
Q3 		$119K Sell
31
-15
-33% -$47.3K ﹤0.01% 2428
2021
Q2 		$132K Buy
+46
New +$109K ﹤0.01% 2438

Other funds holding PAVM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PAVM Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 31 shares — an estimated $119K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $132K in Q2 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 31 PAVmed shares in Q4 2021, an estimated $119K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s PAVmed position peaked at $132K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.